Cardiac Imaging for Coronary Heart Disease Risk Stratification in Chronic Kidney Disease

Area of Science:

• Nephrology
• Cardiology
• Medical Imaging

Background:

• Chronic kidney disease (CKD) is a major independent risk factor for coronary artery disease (CAD).
• CKD patients face substantially higher cardiovascular mortality than the general population.
• Cardiovascular risk in CKD correlates with renal dysfunction severity and microalbuminuria.

Purpose of the Study:

• To review optimal strategies for evaluating CAD in CKD patients, particularly pre-transplant.
• To discuss challenges in CAD assessment due to renal dysfunction and contrast agent risks.
• To highlight alternative imaging modalities for assessing obstructive CAD and cardiomyopathy in advanced CKD.

Main Methods:

• Review of existing literature on CAD evaluation in CKD.
• Discussion of limitations of contrast-enhanced imaging (radiographic, MRI, CT angiography) in CKD.
• Exploration of non-contrast imaging techniques: echocardiography, non-contrast MRI, nuclear myocardial perfusion, and metabolic imaging.

Main Results:

• Severe renal dysfunction limits contrast agent use due to nephrotoxicity and systemic sclerosis risks.
• Premature medial calcification in CKD can reduce the diagnostic accuracy of CT angiography.
• Non-contrast imaging offers viable alternatives for assessing CAD and cardiomyopathy in CKD.

Conclusions:

• Optimal CAD evaluation in CKD, especially pre-transplant, remains challenging.
• Non-contrast imaging modalities are essential for safe and effective CAD assessment in CKD patients.
• Echocardiography, non-contrast MRI, and nuclear imaging provide valuable diagnostic information without nephrotoxic agents.